Related Experiment Videos
Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies
Damian C Crowther1, Didier Belorgey, Elena Miranda
11Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 2XY, UK.
European Journal of Human Genetics : EJHG
|December 25, 2003
Summary
Alpha-1-antitrypsin deficiency, caused by the Z allele, leads to liver disease and emphysema due to protein buildup in hepatocytes. This serpinopathy mechanism explains other related genetic disorders.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Alpha-1-antitrypsin (alpha(1)-antitrypsin) is a key serpin.
- The Z allele causes alpha(1)-antitrypsin deficiency, leading to liver disease and emphysema.
- Deficiency results from protein misfolding, polymerization, and retention in hepatocytes.
Purpose of the Study:
- To review the genetic and molecular basis of alpha(1)-antitrypsin deficiency.
- To explore the clinical features of alpha(1)-antitrypsin deficiency.
- To elucidate how alpha(1)-antitrypsin deficiency serves as a model for understanding serpinopathies.
Main Methods:
- Literature review of genetic and molecular studies.
- Analysis of clinical data associated with alpha(1)-antitrypsin deficiency.
- Comparative analysis of serpinopathies.
Main Results:
- The Z allele of alpha(1)-antitrypsin leads to intracellular protein accumulation and deficiency.
- This polymerization mechanism underlies various serpinopathies, including thrombosis, angio-oedema, and dementia.
- Mutant alleles of antithrombin, C1-inhibitor, alpha(1)-antichymotrypsin, and neuroserpin cause distinct diseases.
Conclusions:
- Alpha(1)-antitrypsin deficiency provides a framework for understanding serpinopathies.
- Aberrant protein polymerization is a common pathogenic mechanism in serpinopathies.
- Understanding these mechanisms is crucial for developing therapeutic strategies.